Gene Therapy of Sphingolipid Metabolic Disorders

Sphingolipidoses are defined as a group of rare hereditary diseases resulting from mutations in the genes encoding lysosomal enzymes. This group of lysosomal storage diseases includes more than 10 genetic disorders, including GM1-gangliosidosis, Tay–Sachs disease, Sandhoff disease, the AB variant of...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaimardanova, Alisa A., Solovyeva, Valeriya V., Issa, Shaza S., Rizvanov, Albert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964151/
https://www.ncbi.nlm.nih.gov/pubmed/36835039
http://dx.doi.org/10.3390/ijms24043627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964151/
https://www.ncbi.nlm.nih.gov/pubmed/36835039
http://dx.doi.org/10.3390/ijms24043627

Ejemplares similares